Pipeline
Our Pipeline
Interferon-β (VXD301)
Overview
IFN-β is an antiviral cytokine which performs immune regulation, being tasked with a core role in innate immune activation. Vaxdigm stably produces recombinant IFN-β using ChaperNova™ , and intends to promote it as RUO (Research use only) for high-functioning proteins. Through this, we aim to develop IFN-β as a standard protein to be used in various biological research fields such antivirus research and immune response analysis.
Our Pipeline
Interferon-β (VXD301)
Overview
IFN-β is an antiviral cytokine which performs immune regulation, being tasked with a core role in innate immune activation. Vaxdigm stably produces recombinant IFN-β using ChaperNovaTM, and intends to promote it as RUO (Research use only) for high-functioning proteins. Through this, we aim to develop IFN-β as a standard protein to be used in various biological research fields such antivirus research and immune response analysis.
Vaxdigm Co., Ltd.
CEO Sung Jae Kim
TEL 02-6205-2550
EMAIL hydrogold@vaxdigm.com
BUSINESS NUMBER 657-87-02464
ADDRESS 412ho, 201, Songpa-daero, Songpa-gu, Seoul, Republic of Korea
PRIVACY POLICYㅣTERMS AND CONDITIONS
COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.
Vaxdigm Co., Ltd.
CEO Sung Jae Kim
EMAIL hydrogold@vaxdigm.com ㅣ TEL 02-6205-2550
BUSINESS NUMBER 657-87-02464 ㅣ ADDRESS 412ho, 201, Songpa-daero, Sonpa-gu, Seoul, Republic of Korea
PRIVACY POLICYㅣTERMS AND CONDITIONS
COPYRIGHT © 2026 VAXDIGM. ALL RIGHTS RESERVED.
